Recombinant Neisseria meningitidis serogroup B Ribosome maturation factor RimP (rimP)

Shipped with Ice Packs
In Stock

Description

Factor H Binding Protein (fHbp)

  • A surface-exposed lipoprotein expressed by >95% of serogroup B strains .

  • Vaccine utility: Trumenba® contains lipidated fHbp variants from subfamilies A and B, inducing bactericidal antibodies against diverse strains .

LP2086 Antigen

  • A lipoprotein present in all N. meningitidis serogroup B strains .

  • Vaccine design: Recombinant LP2086 (rLP2086) elicits cross-reactive bactericidal antibodies, with two subfamilies (A and B) providing broad coverage .

4CMenB Vaccine

  • Contains fHbp, NHBA, NadA, and PorA proteins .

  • Effectiveness: 79–100% against serogroup B invasive disease in clinical trials .

Comparative Analysis of Meningococcal Vaccine Antigens

AntigenFunctionVaccine CoverageKey Findings
fHbpEvades complement-mediated lysis69–95% Lipidated form critical for cross-reactivity
LP2086Surface-exposed lipoproteinBroad Subfamily A/B mixing enhances coverage
PorAOuter membrane porinStrain-specificHexavalent PorA vaccines under study
RimPRibosomal assembly (hypothetical)N/ANot yet explored in N. meningitidis

Research Gaps and Future Directions

  1. RimP in *N. meningitidis*: No direct studies on RimP’s role in meningococcal ribosome biogenesis or its potential as a vaccine target exist in the provided literature.

  2. Antigen synergy: Combining RimP-like ribosomal factors with surface antigens (e.g., fHbp) could enhance vaccine efficacy, as seen with LP2086 + PorA combinations .

  3. Structural insights: Crystal structures of RimP homologs (e.g., MSMEG_2624) may guide drug design against ribosomal targets in M. tuberculosis, with potential applicability to other pathogens .

Product Specs

Form
Lyophilized powder. We will ship the in-stock format by default. For specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. Proteins ship with standard blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon arrival. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us for preferential development.
Synonyms
rimP; NMB1641; Ribosome maturation factor RimP
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-149
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Neisseria meningitidis serogroup B (strain MC58)
Target Names
rimP
Target Protein Sequence
MYIGSSMDIQ TILEKTLPGL GYELVDFELT AQGTLRVFID KESGITVEDC ATVSNHLSRV FMVEDIDYKN LEISSPGLDR PLKKAADFVR FAGQNAKIKT RLPIDGQKNF IGKIEGCEND TVTVSFDGKT VQIELGNIDK ARLRPEFKF
Uniprot No.

Target Background

Function
Essential for the maturation of 30S ribosomal subunits.
Database Links

KEGG: nme:NMB1641

STRING: 122586.NMB1641

Protein Families
RimP family
Subcellular Location
Cytoplasm.

Q&A

What is RimP and what is its functional significance in Neisseria meningitidis?

RimP (Ribosome Maturation Factor P) is an essential protein involved in ribosomal biogenesis, specifically in the formation of the 30S small ribosomal subunit in bacteria. In Neisseria meningitidis, as in other bacterial species, RimP plays a critical role in ensuring proper assembly of ribosomes, which are essential for protein synthesis . Research indicates that in the absence of RimP, the central pseudoknot structure of rRNA becomes unstable, leading to the accumulation of immature ribosomal intermediates that lack crucial ribosomal proteins such as S5 and S12 .

Experimental approaches to characterize RimP function typically involve gene knockout or depletion studies followed by ribosomal profiling to assess the impact on 30S subunit assembly. Complementation experiments can confirm function by restoring wild-type RimP expression in knockout strains. Polysome profile analysis and ribosome sedimentation studies are valuable methodologies for assessing ribosomal assembly defects that occur in the absence of functional RimP.

How is the structure of RimP related to its function in ribosomal biogenesis?

Structural studies of RimP homologs, particularly the high-resolution crystal structure from Mycobacterium smegmatis, reveal that RimP contains two distinct domains with a well-defined interdomain orientation . These domains cooperatively bind with the small ribosomal protein RpsL (S12) through RimP's linker region, which appears to be essential for proper ribosomal biogenesis .

The linker region contains evolutionarily conserved residues that form a platform for recruiting S12 and facilitating rRNA binding . When examining RimP structure-function relationships, researchers should consider:

  • Domain interactions and their cooperative binding mechanisms

  • Conservation of critical residues across bacterial species

  • Specific binding interfaces with ribosomal proteins and rRNA

  • Conformational changes that might occur during ribosome assembly

X-ray crystallography, cryo-electron microscopy, and protein-protein interaction studies using methods such as surface plasmon resonance can provide insights into these structural aspects.

What experimental approaches are recommended for expressing and purifying recombinant RimP from Neisseria meningitidis?

For successful expression and purification of recombinant Neisseria meningitidis RimP, researchers should consider the following methodological approach:

  • Gene cloning: The rimP gene should be amplified from N. meningitidis genomic DNA using PCR with appropriate primers containing restriction sites for subsequent cloning into an expression vector .

  • Expression system selection: Escherichia coli expression systems are commonly used for recombinant bacterial protein production. BL21(DE3) strains are generally suitable for RimP expression .

  • Vector selection: pET-based vectors with histidine tags facilitate purification using metal affinity chromatography. The optimal tag position (N- or C-terminal) should be determined empirically.

  • Expression conditions: Induction with IPTG (isopropyl β-D-1-thiogalactopyranoside) at concentrations between 0.1-1.0 mM when cultures reach OD600 0.6-0.8, followed by incubation at lower temperatures (16-25°C) can improve soluble protein yield .

  • Purification strategy: Ni-NTA affinity chromatography is effective for His-tagged RimP purification, followed by size exclusion chromatography to achieve higher purity .

  • Protein verification: SDS-PAGE and western blotting with anti-His antibodies confirm successful expression and purification .

For difficult-to-express proteins, alternative approaches include fusion partners (MBP, GST, SUMO), different E. coli strains (Rosetta for rare codon optimization), or cell-free expression systems.

How does the interaction between RimP and ribosomal proteins contribute to 30S subunit assembly in Neisseria meningitidis?

The interaction between RimP and ribosomal proteins, particularly RpsL (S12), is crucial for proper 30S subunit assembly. Based on structural and biochemical studies of RimP homologs, the linker region between the two domains of RimP forms a platform for recruiting S12 and facilitating its association with the central pseudoknot structure of 16S rRNA .

Research suggests that in the absence of RimP, the central pseudoknot structure becomes unstable, leading to accumulation of assembly intermediates that lack critical pseudoknot-interacting ribosomal proteins S5 and S12 . This implies a sequential assembly model where:

  • RimP binds to nascent 16S rRNA

  • RimP recruits S12 through its conserved linker region

  • S12 association stabilizes the central pseudoknot structure

  • Additional proteins (including S5) can then properly associate

  • RimP likely dissociates after facilitating these interactions

To study these interactions, researchers can employ:

  • Pull-down assays with tagged RimP to identify interacting ribosomal proteins

  • In vitro reconstitution experiments with purified components

  • Structural studies using cryo-EM to visualize assembly intermediates

  • Mutational analysis of the linker region to identify critical residues

  • Time-resolved experiments to map the kinetics of assembly

The cooperative nature of these interactions suggests that disruption of RimP function would have cascading effects on ribosome assembly and ultimately bacterial viability.

What is the relationship between RimP function and antibiotic resistance in Neisseria meningitidis?

While direct evidence linking RimP to antibiotic resistance mechanisms in Neisseria meningitidis is limited in the provided search results, several conceptual connections can be made that warrant investigation:

  • Rifampicin resistance: Studies have identified rifampicin-resistant N. meningitidis isolates (0.20% fully resistant with MIC >1 mg/L and 0.69% intermediate-resistant with MICs between 0.38-1 mg/L) . Rifampicin targets RNA polymerase, affecting transcription rather than translation directly, but altered ribosome assembly due to RimP dysfunction could potentially influence susceptibility to translation-targeting antibiotics.

  • Altered ribosome composition: Since RimP plays a role in proper 30S subunit assembly, mutations or expression changes in RimP could theoretically lead to altered ribosome composition or structure that might affect binding of translation-targeting antibiotics.

  • Stress response: Ribosome assembly defects caused by RimP dysfunction could trigger bacterial stress responses that may indirectly contribute to antibiotic tolerance.

Research methodologies to investigate these relationships should include:

  • Comparative genomic analysis of rimP sequences in antibiotic-resistant versus susceptible isolates

  • Transcriptomic and proteomic profiling of antibiotic-resistant strains to assess RimP expression levels

  • Generation of RimP overexpression and depletion strains to test antibiotic susceptibility changes

  • Structural studies to determine if RimP-dependent alterations in ribosome assembly affect antibiotic binding sites

Table 1: Rifampicin Resistance Profiles in N. meningitidis Clinical Isolates (2002-2007)

Resistance CategoryNumber of IsolatesPercentageMIC Range
Sensitive386999.11%<0.38 mg/L
Intermediate270.69%0.38-1 mg/L
Resistant80.20%>1 mg/L
Total3904100%-

Data from the French Meningococcal Reference Centre

How can researchers effectively design experiments to study RimP function in Neisseria meningitidis?

Effective experimental design for studying RimP function in N. meningitidis should incorporate three key principles: randomization, replication, and blocking3.

Randomization: To minimize bias, researchers should randomize:

  • Selection of bacterial strains for genetic manipulation

  • Assignment of treatment conditions

  • Order of sample processing and analysis

  • Selection of timepoints for data collection

Replication: Proper replication ensures robust and reliable results3:

  • Biological replicates: Use multiple independent bacterial cultures grown from different colonies

  • Technical replicates: Repeat measurements from the same biological sample

  • Temporal replication: Repeat entire experiments on different days

  • Minimum recommended replication: 3 biological replicates with 2-3 technical replicates each

Blocking: Control for known sources of variability by stratifying experiments3:

  • Growth conditions (media batches, incubation equipment)

  • Genetic background (clinical isolates vs. laboratory strains)

  • Growth phase (exponential vs. stationary)

For RimP functional studies specifically, consider the following experimental design elements:

  • Gene manipulation approaches:

    • Clean deletion mutants with complementation controls

    • Conditional expression systems (inducible/repressible promoters)

    • Point mutations targeting conserved residues in the linker region

  • Phenotypic characterization:

    • Growth curve analysis under various conditions

    • Ribosome profiling using sucrose gradient centrifugation

    • Protein synthesis rates using radioisotope incorporation

    • Antibiotic susceptibility testing

  • Molecular interaction studies:

    • Co-immunoprecipitation with ribosomal proteins

    • Surface plasmon resonance for binding kinetics

    • Structural analysis by cryo-EM or X-ray crystallography

Table 2: Experimental Design Matrix for RimP Functional Studies

Research QuestionApproachControlsMeasurementsAnalysis Method
Is RimP essential?Conditional depletionWild-type strain, Empty vectorGrowth rate, Cell viabilityGrowth curve analysis, CFU counting
What proteins interact with RimP?Co-immunoprecipitationNon-specific antibody, Untagged strainInteracting proteinsMass spectrometry, Western blot
How does RimP affect ribosome assembly?Sucrose gradient centrifugationWild-type, Known assembly mutantsRibosomal subunit profilesA260 absorbance profiles, RNA-seq of fractions
Which RimP residues are critical?Site-directed mutagenesisWild-type, Known inactive mutantComplementation efficiencyGrowth restoration, Ribosome profiles
How does RimP depletion affect gene expression?RNA-seq after conditional depletionWild-type, Samples at multiple timepointsTranscriptome changesDifferential expression analysis

What are the challenges and solutions in studying RimP-dependent ribosome assembly intermediates?

Studying RimP-dependent ribosome assembly intermediates presents several technical challenges that require specialized methodological approaches:

Challenges:

  • Transient nature of assembly intermediates: Ribosome assembly occurs rapidly, making capture of intermediates difficult.

  • Heterogeneity of intermediates: Assembly does not proceed through a single pathway, resulting in diverse intermediate populations.

  • Low abundance: Assembly intermediates typically represent a small fraction of cellular ribosomal components.

  • Technical limitations: Standard techniques may not adequately separate or identify specific intermediates.

  • Function-structure relationships: Connecting observed structural features to functional significance is complex.

Methodological Solutions:

  • Strain Engineering Approaches:

    • Temperature-sensitive RimP mutants that allow controlled inactivation

    • Depletion strains using inducible/repressible systems

    • Strategic point mutations that slow but don't abolish function

  • Isolation and Characterization Methods:

    • Sucrose density gradient ultracentrifugation with expanded gradients

    • Affinity purification using tagged ribosomal proteins or RimP

    • Specialized ribosome profiling to capture assembly-specific signatures

  • Structural Analysis:

    • Cryo-electron microscopy with advanced particle classification

    • Chemical probing methods (SHAPE, DMS) to assess rRNA structure

    • Mass spectrometry approaches to determine protein composition

  • Kinetic Approaches:

    • Pulse-chase experiments with labeled rRNA/proteins

    • Time-resolved structural studies

    • Single-molecule tracking of assembly factors

Table 3: Methodological Approaches for Studying RimP-Dependent Assembly Intermediates

MethodInformation ProvidedAdvantagesLimitations
Sucrose gradient ultracentrifugationSedimentation profiles of assembly intermediatesSimple technique, well-establishedLimited resolution, sample dilution
Quantitative mass spectrometryProtein composition of intermediatesPrecise identification of componentsRequires specialized equipment, complex analysis
Cryo-EMStructural details of intermediatesNear-atomic resolution possibleComputationally intensive, sample preparation challenges
Chemical probingRNA structure in intermediatesCan be performed in vivoIndirect structural information, complex analysis
RNA-seq of gradient fractionsRNA components of intermediatesHigh sensitivity, transcriptome-wideRequires significant bioinformatic analysis
Fluorescence-based assaysReal-time assembly dynamicsCan track assembly in vivoRequires genetic modification, potential artifacts

A combined approach using multiple methods provides the most comprehensive understanding of RimP's role in ribosome assembly.

How does RimP from Neisseria meningitidis compare to homologs in other bacterial species?

Comparative analysis of RimP across bacterial species provides valuable insights into conserved functional domains and species-specific adaptations. While the search results mainly provide detailed information about RimP from Mycobacterium smegmatis , this can serve as a reference point for comparing with N. meningitidis RimP.

Structural Comparison:
The high-resolution crystal structure of M. smegmatis RimP reveals two distinct domains with a well-defined interdomain orientation . This general architecture is likely conserved in N. meningitidis RimP, but with potential differences in:

  • Interdomain linker length and composition

  • Surface charge distribution

  • Specific binding interfaces for ribosomal components

  • Presence of species-specific structural elements

Functional Conservation:
The fundamental role of RimP in 30S ribosomal subunit assembly appears conserved across bacterial species. In both E. coli and M. smegmatis, RimP is essential for proper ribosome biogenesis . The critical function of the linker region in binding ribosomal protein S12 (RpsL) and facilitating rRNA binding is likely conserved in N. meningitidis as well.

Methodological Approaches for Comparative Studies:

  • Sequence analysis:

    • Multiple sequence alignment of RimP proteins

    • Phylogenetic analysis to map evolutionary relationships

    • Conservation mapping onto structural models

  • Complementation studies:

    • Express N. meningitidis RimP in E. coli or M. smegmatis rimP deletion strains

    • Test functional complementation across species boundaries

    • Identify domains responsible for species-specific functions

  • Chimeric protein analysis:

    • Generate domain-swapped versions between species

    • Test functionality of chimeric proteins

    • Map species-specific functional regions

Table 4: Comparative Features of RimP Across Bacterial Species

FeatureN. meningitidisM. smegmatisE. coliFunctional Significance
Domain structureTwo domains with linker*Two domains with well-defined interdomain orientation Two domains with linkerCore architecture conserved for ribosomal interaction
Linker regionLikely contains conserved residues*Contains evolutionarily conserved residues Contains functionally important residuesEssential for S12 binding and ribosome assembly
Binding partnersPredicted to include S12 (RpsL)*Binds RpsL through linker region Interacts with 16S rRNA and ribosomal proteinsConserved interaction with core ribosomal components
Essential naturePredicted to be essential*Essential for ribosome biogenesis Essential for biogenesis of 30S subunit Core function in ribosome assembly is conserved
Species-specific featuresTo be determinedSpecific structural features from crystal structure Characterized binding sites and mutant phenotypesMay reflect adaptation to specific ribosome structures

*Predicted based on homology and conservation patterns, not directly evidenced in search results

What is the potential of RimP as a target for antimicrobial development against Neisseria meningitidis?

Given RimP's essential role in ribosome biogenesis, it represents a potential target for novel antimicrobial development against N. meningitidis. While the search results don't directly address this application, several rational approaches can be derived from current understanding:

  • Target Validation Approach:

    • Generate conditional RimP depletion strains to confirm essentiality in N. meningitidis

    • Validate growth inhibition upon RimP depletion under various conditions

    • Evaluate impact of partial inhibition on bacterial fitness and virulence

  • Drug Discovery Strategies:

    • Structure-based virtual screening using RimP crystal structure as template

    • Fragment-based approach targeting the linker region that interacts with S12

    • High-throughput screening of compound libraries using RimP-S12 binding assays

    • Peptide mimetics based on the binding interface

  • Specificity Considerations:

    • Compare RimP structures across bacterial pathogens and human cells

    • Target regions unique to bacterial RimP proteins

    • Design assays to assess selectivity for bacterial versus human cellular targets

  • Resistance Development Assessment:

    • Frequency of spontaneous resistance

    • Mechanisms of potential resistance (target modification, efflux, bypass)

    • Cross-resistance with existing antibiotics

Table 5: Advantages and Challenges of RimP as an Antimicrobial Target

AdvantagesChallengesMitigation Strategies
Essential protein without human homologPotential for rapid resistance developmentCombination therapy approaches
Well-defined structure with targetable interfacesIntracellular target requiring membrane penetrationMedicinal chemistry for improved penetration
Different from traditional antibiotic targetsLimited clinical precedent for ribosome assembly inhibitorsRobust in vitro and in vivo validation
Potential broad-spectrum activitySpecies-specific structural differencesStructure-guided drug design
May be effective against dormant bacteriaComplex protein-protein interactionsFragment-based approaches

How can RimP research contribute to vaccine development against Neisseria meningitidis serogroup B?

Although RimP is primarily an intracellular ribosomal assembly factor not typically considered for vaccine development, its research contributes to understanding N. meningitidis biology and potentially to vaccine approaches:

  • Contribution to Basic Knowledge:
    Research on RimP enhances understanding of N. meningitidis gene expression machinery, potentially informing vaccine antigen design and production. The ribosomal maturation process impacts expression of all proteins, including those targeted in vaccines.

  • Recombinant Protein Production:
    Methodologies developed for RimP expression and purification can inform production of other N. meningitidis recombinant proteins for vaccine development .

  • Risk Management Considerations:
    Research on fundamental N. meningitidis biology contributes to risk management plans for vaccines, such as the bivalent recombinant lipoprotein vaccine discussed in search result .

  • Indirect Applications:

    • Understanding translation efficiency may help optimize expression of vaccine candidates

    • Identification of RimP-dependent genes may reveal new surface-exposed antigens

    • Knowledge of ribosome function may inform attenuation strategies for live vaccines

The search results indicate ongoing vaccine development efforts against N. meningitidis serogroup B using recombinant lipoproteins . While RimP itself is not mentioned as a vaccine component, the regulatory documentation shows systematic evaluation of:

  • Target population demographics

  • Clinical trial exposure data

  • Post-authorization experience

  • Risk management planning

  • Missing information identification

Table 6: Current N. meningitidis Serogroup B Vaccine Development Status

AspectDetailsSource
Target PopulationIndividuals 10 years and older
Key ComponentsRecombinant factor H binding proteins (fHbp)
Dosing RegimenTwo doses (0.5 mL each) at 6-month interval or three doses with specific timing
Production MethodProteins individually produced in E. coli, extracted and purified
Composition60 μg of each fHbp variant (120 μg total), with adjuvant
Safety MonitoringUpdated risk management plan through March 2024
EpidemiologySerogroup B accounts for approximately 62% of cases in Europe

What are the optimal methods for genetic manipulation of rimP in Neisseria meningitidis?

Genetic manipulation of N. meningitidis presents unique challenges due to this organism's natural competence, specific growth requirements, and transformation barriers. For rimP modification, researchers should consider these methodological approaches:

  • Allelic Replacement Strategies:

    • Construct vectors containing upstream and downstream homologous regions flanking the desired modification

    • Include selectable markers (antibiotic resistance genes) for positive selection

    • Consider counter-selectable markers (e.g., sacB) for seamless modifications

    • Optimize homology arm lengths (typically 500-1000 bp) for efficient recombination

  • Conditional Expression Systems:

    • For essential genes like rimP, use inducible/repressible promoter systems

    • Options include tet-responsive elements, IPTG-inducible systems, or riboswitches

    • Ensure tight regulation to prevent leaky expression

    • Validate system dynamics using reporter genes before targeting rimP

  • CRISPR-Cas9 Based Approaches:

    • Design sgRNAs targeting specific regions of rimP

    • Provide repair templates for homology-directed repair

    • Optimize Cas9 expression for N. meningitidis

    • Screen for off-target effects

  • Transformation Considerations:

    • Use piliated strains with high competence

    • Optimize DNA concentration and methylation status

    • Consider restriction barriers and use host-mimicking methylation

    • Include DUS (DNA uptake sequence) elements in constructs

  • Verification Methods:

    • PCR verification with primers flanking the modified region

    • Sequencing to confirm precise modifications

    • Quantitative RT-PCR for expression changes

    • Western blotting to verify protein levels

Table 7: Comparative Analysis of Genetic Manipulation Methods for rimP in N. meningitidis

MethodAdvantagesLimitationsBest Application Scenario
Allelic exchangeWell-established, relatively efficientTime-consuming, multiple recombination eventsComplete gene deletion, small modifications
Conditional expressionAllows study of essential genesSystem leakiness, non-native expression levelsDepletion studies, dominant negative approaches
CRISPR-Cas9Precise editing, potentially higher efficiencyOptimization for N. meningitidis needed, off-target effectsPoint mutations, scarless editing
Transposon mutagenesisHigh-throughput, genome-wideRandom insertions, polar effectsInitial screening for non-essential regions
Antisense RNARelatively simple, tunableIncomplete knockdown, off-target effectsRapid assessment of gene importance

How can researchers effectively analyze the impact of RimP on the N. meningitidis proteome?

Understanding how RimP affects the global proteome of N. meningitidis requires comprehensive analytical approaches that capture both direct effects on translation and indirect consequences of altered ribosome assembly:

  • Quantitative Proteomics Approaches:

    • SILAC (Stable Isotope Labeling with Amino acids in Cell culture)

    • TMT (Tandem Mass Tag) or iTRAQ (Isobaric Tags for Relative and Absolute Quantitation)

    • Label-free quantification methods

    • Targeted proteomics (SRM/MRM) for specific proteins of interest

  • Ribosome Profiling:

    • Nuclease footprinting of translating ribosomes

    • Deep sequencing of ribosome-protected fragments

    • Analysis of translation efficiency across the transcriptome

    • Identification of translational stalling or frameshifting events

  • Polysome Analysis:

    • Sucrose gradient fractionation to separate monosomes from polysomes

    • RNA-seq of gradient fractions to identify translationally regulated mRNAs

    • Proteomic analysis of ribosome-associated proteins across fractions

    • Assessment of non-canonical translation products

  • Post-translational Modification Analysis:

    • Phosphoproteomics to detect signaling changes

    • Analysis of stress-induced modifications

    • Quantitation of protein stability and turnover rates

    • Identification of misfolded protein accumulation

Experimental Design Considerations:

When analyzing RimP's impact on the proteome, researchers should employ the principles of:

  • Randomization: Randomly assign cultures to treatment groups and processing order3

  • Replication: Include sufficient biological and technical replicates (minimum 3)3

  • Blocking: Control for batch effects in sample preparation and analysis3

Data Analysis Framework:

  • Primary Analysis:

    • Protein identification and quantification

    • Statistical analysis of differential abundance

    • Pathway enrichment analysis

    • Protein-protein interaction network mapping

  • Secondary Analysis:

    • Correlation with transcriptomic data

    • Structural classification of affected proteins

    • Motif analysis of differentially translated mRNAs

    • Codon usage bias assessment

  • Functional Validation:

    • Targeted deletion or overexpression of key identified proteins

    • Phenotypic assays to assess functional consequences

    • In vitro translation assays with purified components

    • Structural biology approaches for key interactions

Table 8: Analytical Methods for Assessing RimP's Impact on the Proteome

Analytical ApproachPrimary Data OutputStrengthsWeaknessesKey Applications
LC-MS/MS with TMT LabelingRelative protein abundance across conditionsMultiplex capability, high throughputRatio compression, complex sample prepGlobal proteome shifts
SILACPrecise relative quantificationAccurate ratios, good reproducibilityLimited multiplexing, metabolic labeling requiredDirect comparison of wild-type vs. RimP-depleted
Ribosome ProfilingGenome-wide translation efficiencyNucleotide resolution, captures translation dynamicsComplex library prep, high sequencing depth requiredIdentifying translation efficiency changes
Pulse-SILACProtein synthesis and degradation ratesDistinguishes synthesis vs. stability effectsComplex experimental setupMeasuring kinetic effects of RimP depletion
Proteome FractionationSubcellular localization changesReveals protein mislocalizationLabor intensive, potential cross-contaminationUnderstanding trafficking defects

By combining these approaches, researchers can develop a comprehensive understanding of how RimP influences the N. meningitidis proteome, providing insights into both basic biology and potential therapeutic interventions.

What are the current knowledge gaps in RimP research and future directions?

Despite advances in understanding RimP function, significant knowledge gaps remain that present opportunities for future research:

  • Structural Specificity in N. meningitidis:
    While structural information exists for RimP homologs in other species such as M. smegmatis , N. meningitidis-specific structural features remain largely unexplored. Future studies should determine the crystal or cryo-EM structure of N. meningitidis RimP to identify unique structural features that may influence function.

  • Temporal Dynamics of RimP Action:
    The precise timing and dynamics of RimP association and dissociation during ribosome assembly remain unclear. Time-resolved studies using techniques such as single-molecule fluorescence or pulse-chase experiments would provide valuable insights into these dynamics.

  • Regulatory Mechanisms:
    Little is known about how RimP expression and activity are regulated in response to changing environmental conditions. Transcriptomic and proteomic studies under various stress conditions would help elucidate these regulatory networks.

  • Interactions with Other Assembly Factors:
    RimP likely functions within a broader network of ribosome assembly factors. Comprehensive protein-protein interaction studies would help map this network and understand cooperative or competitive interactions.

  • Host-Pathogen Interactions:
    The potential role of RimP in N. meningitidis virulence and host interaction remains unexplored. Studies in infection models could reveal whether RimP-dependent translation affects virulence factor expression.

Future Research Directions:

  • Comparative Studies:

    • Cross-species analysis of RimP structure and function

    • Evolutionary analysis of conserved and variable regions

    • Identification of species-specific adaptations

  • Systems Biology Approaches:

    • Integration of transcriptomic, proteomic, and structural data

    • Network analysis of ribosome assembly pathways

    • Mathematical modeling of assembly dynamics

  • Translational Applications:

    • High-throughput screening for RimP inhibitors

    • Structure-based drug design targeting specific RimP interfaces

    • Development of diagnostic tools based on RimP biology

  • Technical Innovations:

    • Application of advanced mass spectrometry for assembly intermediate characterization

    • Development of RimP-specific biosensors

    • Single-cell analysis of RimP function

Table 9: Priority Research Areas for N. meningitidis RimP

Research AreaKnowledge GapProposed MethodologiesPotential Impact
Structural BiologyN. meningitidis-specific RimP structureX-ray crystallography, Cryo-EMStructure-based drug design opportunities
Functional GenomicsGenome-wide effects of RimP depletionRNA-seq, Ribo-seq, ProteomicsUnderstanding regulatory networks
Drug DiscoveryRimP as antimicrobial targetHigh-throughput screening, Medicinal chemistryNovel therapeutic approaches
Evolutionary BiologyConservation and divergence across speciesPhylogenetic analysis, Structural comparisonInsights into species-specific adaptations
Diagnostic DevelopmentRimP as biomarkerAntibody development, PCR-based detectionImproved N. meningitidis diagnostics

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.